AMELI-BIOGROUP LTD

Clinical Trial Site/Site NetworkPrivate Company

London, United Kingdom

Website LinkedIn

2024

Founded

1-10

Employees

Trials supported

About AMELI-BIOGROUP LTD

Ameli-Biogroup Ltd is a physician-led clinical research site partnered with leading pharmaceutical companies to execute rare-disease and specialty trials. Founded on a philosophy of clinician-driven innovation, cultural inclusivity, and community engagement, our site has developed a unique, original model to address critical unmet needs in patient recruitment, operational efficiency, diversity and inclusion, and patient and staff experience. In our inaugural rare-disease trial, we achieved full enrolment within four months of site activation—far surpassing industry norms. We built and moderated disease-specific online communities, forged culturally sensitive partnerships with ethnic minority groups (including Islamic, Togolese, and Togolese diaspora communities), and leveraged a robust general practitioner (GP) and specialist referral network. This narrative details our comprehensive approach, quantifies the operational impact, and illustrates how our replicable blueprint fosters equitable and efficient clinical research.

Therapeutic areas

Digital Health Rare Diseases Cardiology Dermatology Gastroenterology Infectious Diseases Substance Abuse Respiratory Metabolism and Endocrinology Immunology

Experience & capabilities

Products:Medical DevicesVaccinesDiagnostics

Trial geography:United Kingdom

Languages:EnglishSpanishGermanHindiFrench

Team

Dr Anthony AvornyoMedical Director
Nimsha SadikhProject Manager